Ho-Yeon Chung
Overview
Explore the profile of Ho-Yeon Chung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cho I, Oh D, Yoo J, Hwang Y, Ahn K, Chung H, et al.
Sci Rep
. 2021 May;
11(1):9894.
PMID: 33972568
Excess fructose consumption contributes to development obesity, metabolic syndrome, and nonalcoholic fatty liver disease (NAFLD). Uric acid (UA), a metabolite of fructose metabolism, may have a direct role in development...
2.
Jun J, Kang H, Hwang Y, Ahn K, Chung H, Jeong I
Diabetes Res Clin Pract
. 2020 Dec;
171:108622.
PMID: 33316308
Aims: Lipoprotein (a) [Lp(a)] has been considered a determinant of residual cardiovascular risk. We aimed to investigate associations between serum Lp(a) levels and carotid atherosclerosis. Methods: This cross-sectional study included...
3.
Eo W, Kwon J, An S, Lee S, Kim S, Nam D, et al.
J Cancer
. 2020 Sep;
11(19):5792-5801.
PMID: 32913472
The quantitative and qualitative skeletal muscle parameters have been proposed to predict the outcome of patients with gastric cancer. However, the evidence for their association with long-term survival is still...
4.
Park S, Kang M, Park H, Rhee Y, Moon S, Yoon H, et al.
Arch Osteoporos
. 2019 Dec;
15(1):3.
PMID: 31820121
Introduction: This study investigated the efficacy and safety of once-weekly risedronate with and without cholecalciferol in BMD in Korean patients with osteoporosis. Methods: This was a prospective, 12-month, randomized, open-labeled,...
5.
Park S, Ahn S, Kim H, Jang S, Ha Y, Lee Y, et al.
Spine J
. 2019 Oct;
20(2):225-233.
PMID: 31589928
Background Context: Vertebral fracture is related to an increased risk for subsequent and recurrent osteoporotic fracture as well as increased mortality. However, no study has investigated the exact incidence and...
6.
Byun D, Moon S, Kim T, Lee H, Park H, Kang M, et al.
J Bone Miner Metab
. 2018 Sep;
37(3):563-572.
PMID: 30238428
Patient-reported outcomes (PROs) provide practical guides for treatment; however, studies that have evaluated PROs of women in Korea with postmenopausal osteoporosis (PMO) are lacking. This cross-sectional, multi-center (29 nationwide hospitals)...
7.
Hwang Y, Oh D, Choi M, Lee S, Ahn K, Chung H, et al.
Korean J Intern Med
. 2017 Feb;
33(2):347-355.
PMID: 28142230
Background/aims: Non-alcoholic fatty liver disease is associated with insulin resistance. Compound K (CK) is the final metabolite of panaxadiol ginsenosides that have been shown to exert antidiabetic effects. However, the...
8.
Cho I, Choi K, Oh C, Hwang Y, Jeong I, Ahn K, et al.
Life Sci
. 2015 Dec;
145:1-8.
PMID: 26687448
Aims: Inflammatory processes are involved in bone remodeling. C-reactive protein (CRP) is an acute phase reactant that reflects different degrees of inflammation. Accumulating evidence suggests that CRP is an inflammatory...
9.
Park Y, Kim S, Lim Y, Ha Y, Chang J, Kim I, et al.
J Bone Metab
. 2014 Feb;
20(2):67-74.
PMID: 24524060
Background: Validated simple calcium questionnaires are available to assess the intake of calcium and vitamin D in western countries, but they are not appropriate for Koreans since dairy products are...
10.
Hong S, Koo J, Hwang J, Hwang Y, Jeong I, Ahn K, et al.
J Bone Metab
. 2014 Feb;
20(1):37-41.
PMID: 24524054
Background: Bisphosphonate is used in osteoporosis treatment to repress osteoclast activity, which then decreases levels of osteocalcin (OC). OC, a protein secreted by osteoblasts and released from the bone matrix...